首页 > 最新文献

Ophthalmic epidemiology最新文献

英文 中文
Diabetic Retinopathy Screening Rates at Student-Run Clinics in the United States: A Systematic Review and Meta-Analysis. 美国学生经营诊所的糖尿病视网膜病变筛查率:系统回顾与元分析》。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-30 DOI: 10.1080/09286586.2024.2378778
Nicholas Peoples, Dylan McBee, Shangzhi Xiong, Alexandra Alvarez, Emily Wang, Ashley Ricciardelli, Shiwei Wang, Dana L Clark, Tien Yin Wong
{"title":"Diabetic Retinopathy Screening Rates at Student-Run Clinics in the United States: A Systematic Review and Meta-Analysis.","authors":"Nicholas Peoples, Dylan McBee, Shangzhi Xiong, Alexandra Alvarez, Emily Wang, Ashley Ricciardelli, Shiwei Wang, Dana L Clark, Tien Yin Wong","doi":"10.1080/09286586.2024.2378778","DOIUrl":"10.1080/09286586.2024.2378778","url":null,"abstract":"","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-5"},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142110492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progression in the Number of Cataract Surgeries in Brazil: 10 Years of Evolution. 巴西白内障手术数量的增长:10 年的演变。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-30 DOI: 10.1080/09286586.2024.2378770
Silvana Rossi, Priscilla A Jorge, Rafael Scherer, Newton Kara-Junior

Objective: This study aimed to assess the frequency of cataract surgery in Brazil between 2010 and 2019 and determine the impact of public policies on preventing blindness, thereby providing evidence to conduct healthcare programs.

Methods: An analytical epidemiological approach was employed, which used data from public databases, specifically the Hospital Information System (SIH-SUS) and the Outpatient Information System (SIA-SUS). We focused on cataract surgeries conducted via phacoemulsification and extracapsular cataract extraction techniques between 2010 and 2019, mainly targeting senile cataracts within the Brazilian public health system. Data were analyzed on an annual basis and stratified by region. Trends over time were assessed using generalized additive models.

Results: A statistically significant upward trend in cataract surgeries was observed both nationally and within the South region (p < 0.05). Nationally, there was a 40.22% increase in surgeries between 2010 and 2019. Furthermore, the surgery rate per 1000 individuals aged ≥50 years varied across regions: nationally, it was 10.85, with rates of 9.23 in the Southeast, 13.86 in the Northeast, 9.23 in the South, 11.94 in the Midwest, and 14.2 in the North.

Conclusion: All regions of the country, a satisfactory number of cataract surgeries were performed at some point. Only the Southern region demonstrated a notable upward trend in the number of cataract surgeries. Conversely, the remaining regions failed to sustain surgical performance, hindering consistent improvement in cataract-related conditions. To accurately gauge the prevalence of blindness in Brazil, it is crucial to examine the population growth among individuals aged ≥50 years.

研究目的本研究旨在评估 2010 年至 2019 年间巴西白内障手术的频率,并确定公共政策对防盲的影响,从而为开展医疗保健计划提供证据:研究采用了流行病学分析方法,使用了公共数据库的数据,特别是医院信息系统(SIH-SUS)和门诊信息系统(SIA-SUS)的数据。我们关注的重点是 2010 年至 2019 年期间通过超声乳化和白内障囊外摘除技术进行的白内障手术,主要针对巴西公共卫生系统中的老年性白内障。数据按年度进行分析,并按地区进行分层。使用广义加法模型评估了随时间变化的趋势:全国和南部地区的白内障手术量在统计意义上呈明显上升趋势(p 结论:全国所有地区的白内障手术量都有令人满意的增长:在全国所有地区,白内障手术的数量都令人满意。只有南部地区的白内障手术数量呈明显上升趋势。与此相反,其余地区的白内障手术数量却未能保持稳定,阻碍了白内障相关状况的持续改善。要准确衡量巴西的失明率,关键是要研究年龄≥50 岁的人口增长情况。
{"title":"Progression in the Number of Cataract Surgeries in Brazil: 10 Years of Evolution.","authors":"Silvana Rossi, Priscilla A Jorge, Rafael Scherer, Newton Kara-Junior","doi":"10.1080/09286586.2024.2378770","DOIUrl":"https://doi.org/10.1080/09286586.2024.2378770","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess the frequency of cataract surgery in Brazil between 2010 and 2019 and determine the impact of public policies on preventing blindness, thereby providing evidence to conduct healthcare programs.</p><p><strong>Methods: </strong>An analytical epidemiological approach was employed, which used data from public databases, specifically the Hospital Information System (SIH-SUS) and the Outpatient Information System (SIA-SUS). We focused on cataract surgeries conducted via phacoemulsification and extracapsular cataract extraction techniques between 2010 and 2019, mainly targeting senile cataracts within the Brazilian public health system. Data were analyzed on an annual basis and stratified by region. Trends over time were assessed using generalized additive models.</p><p><strong>Results: </strong>A statistically significant upward trend in cataract surgeries was observed both nationally and within the South region (<i>p</i> < 0.05). Nationally, there was a 40.22% increase in surgeries between 2010 and 2019. Furthermore, the surgery rate per 1000 individuals aged ≥50 years varied across regions: nationally, it was 10.85, with rates of 9.23 in the Southeast, 13.86 in the Northeast, 9.23 in the South, 11.94 in the Midwest, and 14.2 in the North.</p><p><strong>Conclusion: </strong>All regions of the country, a satisfactory number of cataract surgeries were performed at some point. Only the Southern region demonstrated a notable upward trend in the number of cataract surgeries. Conversely, the remaining regions failed to sustain surgical performance, hindering consistent improvement in cataract-related conditions. To accurately gauge the prevalence of blindness in Brazil, it is crucial to examine the population growth among individuals aged ≥50 years.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-8"},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142110494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population-Based Incidence and Clinical Characteristics of Ocular Adnexal Tumors in Olmsted County, Minnesota. 明尼苏达州奥姆斯特德县眼部附件肿瘤的人群发病率和临床特征。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-30 DOI: 10.1080/09286586.2024.2379971
Kenny Y Wang, Timothy T Xu, Mihai G Dumbrava, Kafayat A Oyemade, Johanny Lopez Dominguez, David O Hodge, Launia J White, Andrea A Tooley, Lauren A Dalvin

Purpose: To determine the incidence and clinical characteristics of ocular adnexaltumors in Olmsted County, Minnesota.

Methods: Retrospective population-based cohort study of all patients residing in Olmsted County, Minnesota diagnosed with any ocular tumor from January 1, 2006, to December 31, 2015. The medical records of all patients with an incident diagnosis of any ocular adnexal tumor were reviewed using the Rochester Epidemiology Project medical record linkage system for patient demographics, tumor type, and histopathologic confirmation. Incidence rates were calculated per 100,000 person-years. Poisson regression analysis was used to analyze changes in incidence over time.

Results: There were 717 patients diagnosed with ocular adnexal tumors during the 10-year study period, yielding an age- and sex-adjusted incidence rate of 59.7 per 100,000 (95% CI 55.4 to 64.0, p < 0.05) per year. In total, 764 tumors were diagnosed. Most tumors were eyelid lesions (N = 756, 99.0%), which were mostly benign (N = 512, 67.8%) with epidermal inclusion cysts (N = 275, 36.0%), hidrocystoma (N = 70, 9.2%), and eyelid sebaceous cysts (N = 46, 6.1%) accounting for the majority. Malignant eyelid lesions (N = 244, 31.9%) were relatively common with basal cell carcinoma (N = 184, 24.1%) and squamous cell carcinoma (N = 49, 6.4%) having the highest frequencies. Orbital tumors (N = 8, 1.0%) were infrequent. Of the orbital tumors, the most common was lacrimal gland adenoidcystic carcinoma (N = 2, 25.0%).

Conclusions: In a population-based setting, most ocular adnexal tumors were benign eyelid lesions. Understanding the epidemiology of ocular adnexal tumors is important to aid providers in diagnosing and facilitating appropriate referrals of potentially vision- and life-threatening malignancies.

目的:确定明尼苏达州奥姆斯特德县眼部附件肿瘤的发病率和临床特征:方法:对居住在明尼苏达州奥姆斯特德县的 2006 年 1 月 1 日至 2015 年 12 月 31 日期间确诊患有任何眼部肿瘤的所有患者进行基于人群的回顾性队列研究。研究人员使用罗切斯特流行病学项目(Rochester Epidemiology Project)病历链接系统对所有被诊断为眼部附件肿瘤的患者的病历进行了审查,以了解患者的人口统计学特征、肿瘤类型和组织病理学证实。发病率按每 10 万人年计算。采用泊松回归分析法分析发病率随时间的变化:结果:在 10 年的研究期间,共有 717 名患者被诊断为眼部附件肿瘤,经年龄和性别调整后的发病率为每 10 万人中 59.7 例(95% CI 55.4 至 64.0,P N = 756,99.0%),其中大部分为良性病变(N = 512,67.8%),表皮包涵囊肿(N = 275,36.0%)、息肉囊肿(N = 70,9.2%)和眼睑皮脂腺囊肿(N = 46,6.1%)占大多数。眼睑恶性病变(244 例,31.9%)相对常见,其中基底细胞癌(184 例,24.1%)和鳞状细胞癌(49 例,6.4%)发病率最高。眼眶肿瘤(8 例,1.0%)并不常见。在眼眶肿瘤中,最常见的是泪腺腺样囊性癌(2 例,25.0%):结论:在以人群为基础的环境中,大多数眼部附件肿瘤是眼睑良性病变。了解眼部附件肿瘤的流行病学非常重要,有助于医疗服务提供者对可能危及视力和生命的恶性肿瘤进行诊断和适当转诊。
{"title":"Population-Based Incidence and Clinical Characteristics of Ocular Adnexal Tumors in Olmsted County, Minnesota.","authors":"Kenny Y Wang, Timothy T Xu, Mihai G Dumbrava, Kafayat A Oyemade, Johanny Lopez Dominguez, David O Hodge, Launia J White, Andrea A Tooley, Lauren A Dalvin","doi":"10.1080/09286586.2024.2379971","DOIUrl":"10.1080/09286586.2024.2379971","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the incidence and clinical characteristics of ocular adnexaltumors in Olmsted County, Minnesota.</p><p><strong>Methods: </strong>Retrospective population-based cohort study of all patients residing in Olmsted County, Minnesota diagnosed with any ocular tumor from January 1, 2006, to December 31, 2015. The medical records of all patients with an incident diagnosis of any ocular adnexal tumor were reviewed using the Rochester Epidemiology Project medical record linkage system for patient demographics, tumor type, and histopathologic confirmation. Incidence rates were calculated per 100,000 person-years. Poisson regression analysis was used to analyze changes in incidence over time.</p><p><strong>Results: </strong>There were 717 patients diagnosed with ocular adnexal tumors during the 10-year study period, yielding an age- and sex-adjusted incidence rate of 59.7 per 100,000 (95% CI 55.4 to 64.0, <i>p</i> < 0.05) per year. In total, 764 tumors were diagnosed. Most tumors were eyelid lesions (<i>N</i> = 756, 99.0%), which were mostly benign (<i>N</i> = 512, 67.8%) with epidermal inclusion cysts (<i>N</i> = 275, 36.0%), hidrocystoma (<i>N</i> = 70, 9.2%), and eyelid sebaceous cysts (<i>N</i> = 46, 6.1%) accounting for the majority. Malignant eyelid lesions (<i>N</i> = 244, 31.9%) were relatively common with basal cell carcinoma (<i>N</i> = 184, 24.1%) and squamous cell carcinoma (<i>N</i> = 49, 6.4%) having the highest frequencies. Orbital tumors (<i>N</i> = 8, 1.0%) were infrequent. Of the orbital tumors, the most common was lacrimal gland adenoidcystic carcinoma (<i>N</i> = 2, 25.0%).</p><p><strong>Conclusions: </strong>In a population-based setting, most ocular adnexal tumors were benign eyelid lesions. Understanding the epidemiology of ocular adnexal tumors is important to aid providers in diagnosing and facilitating appropriate referrals of potentially vision- and life-threatening malignancies.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-8"},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142110493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship Between Carotid Artery Stenosis and the Development of Open-Angle Glaucoma: A Long-term Cohort Study in Taiwan. 颈动脉狭窄与开角型青光眼发病的关系:台湾长期队列研究。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-15 DOI: 10.1080/09286586.2024.2371467
Wen-Yun Lin, Jin-Jhe Wang, Chauyin-Yin Chen, Chia-Yen Liu, Meng-Hung Lin, Yao-Hsu Yang, Chien-Hsiung Lai

Purposes: To determine the relationship between carotid artery stenosis (CAS) and the development of open-angle glaucoma (OAG) in the Taiwanese population.

Methods: This retrospective cohort study was conducted using Chang Gung Research Database. Cox-proportional hazards model was applied to calculate the hazard ratio for OAG between CAS and the control cohort.

Results: Among 19,590 CAS patients, 17,238 had mild CAS (<50%), 1,895 had moderate CAS (50-69%), and 457 had severe CAS (≥70%). The CAS cohort had a higher proportion of several comorbidities. After adjusting for comorbidities, no significant difference in OAG development was found between CAS and control cohorts. Matching for key comorbidities, no significant differences in OAG incidence were found between matched cohorts (P = .869). Subdividing the matched CAS cohort by stenosis severity: mild (<50%), moderate (50-69%), and severe (≥70%), a statistically significantly lower OAG risk was observed in patients with mild CAS stenosis (HR: 1.12, 95% CI = 1.03-1.21, = .006). Kaplan-Meier analysis revealed reduced OAG incidence in CAS patients who underwent surgical intervention, compared to the control cohort (P <.001). Subgroup analysis revealed that patients in the mild CAS stenosis group, those who underwent surgical intervention exhibited a reduced OAG risk (HR: 0.29, 95% CI = 0.15-0.58, = .001).

Conclusions: No statistically significant differences in OAG risk were observed between patients with CAS and the control cohort. The severity of CAS appears to influence OAG risk, with surgical intervention potentially offering protective effects, particularly in patients with mild CAS stenosis (<50%), suggesting that enhanced ocular perfusion post-surgery may act as a protective factor against OAG development.

目的确定台湾人群中颈动脉狭窄(CAS)与开角型青光眼(OAG)发病之间的关系:这项回顾性队列研究利用长庚研究数据库进行。方法:这项回顾性队列研究利用长庚研究数据库进行,采用 Cox 比例危险模型计算 CAS 与对照队列之间发生开角型青光眼的危险比:结果:在 19,590 名 CAS 患者中,17,238 人患有轻度 CAS(P = .006)。Kaplan-Meier分析显示,与对照组相比,接受手术干预的CAS患者OAG发病率降低(P = .001):结论:CAS 患者与对照组之间的 OAG 风险无统计学差异。CAS的严重程度似乎会影响OAG风险,手术干预可能会起到保护作用,尤其是对轻度CAS狭窄的患者而言(P = .001)。
{"title":"The Relationship Between Carotid Artery Stenosis and the Development of Open-Angle Glaucoma: A Long-term Cohort Study in Taiwan.","authors":"Wen-Yun Lin, Jin-Jhe Wang, Chauyin-Yin Chen, Chia-Yen Liu, Meng-Hung Lin, Yao-Hsu Yang, Chien-Hsiung Lai","doi":"10.1080/09286586.2024.2371467","DOIUrl":"https://doi.org/10.1080/09286586.2024.2371467","url":null,"abstract":"<p><strong>Purposes: </strong>To determine the relationship between carotid artery stenosis (CAS) and the development of open-angle glaucoma (OAG) in the Taiwanese population.</p><p><strong>Methods: </strong>This retrospective cohort study was conducted using Chang Gung Research Database. Cox-proportional hazards model was applied to calculate the hazard ratio for OAG between CAS and the control cohort.</p><p><strong>Results: </strong>Among 19,590 CAS patients, 17,238 had mild CAS (<50%), 1,895 had moderate CAS (50-69%), and 457 had severe CAS (≥70%). The CAS cohort had a higher proportion of several comorbidities. After adjusting for comorbidities, no significant difference in OAG development was found between CAS and control cohorts. Matching for key comorbidities, no significant differences in OAG incidence were found between matched cohorts (P = .869). Subdividing the matched CAS cohort by stenosis severity: mild (<50%), moderate (50-69%), and severe (≥70%), a statistically significantly lower OAG risk was observed in patients with mild CAS stenosis (HR: 1.12, 95% CI = 1.03-1.21, <i>P </i>= .006). Kaplan-Meier analysis revealed reduced OAG incidence in CAS patients who underwent surgical intervention, compared to the control cohort (<i>P</i> <.001). Subgroup analysis revealed that patients in the mild CAS stenosis group, those who underwent surgical intervention exhibited a reduced OAG risk (HR: 0.29, 95% CI = 0.15-0.58, <i>P </i>= .001).</p><p><strong>Conclusions: </strong>No statistically significant differences in OAG risk were observed between patients with CAS and the control cohort. The severity of CAS appears to influence OAG risk, with surgical intervention potentially offering protective effects, particularly in patients with mild CAS stenosis (<50%), suggesting that enhanced ocular perfusion post-surgery may act as a protective factor against OAG development.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-9"},"PeriodicalIF":1.7,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Gaps in Medical Insurance Coverage with Vision Care Benefits Among US Adults. 美国成年人医疗保险与视力保健福利之间的差距。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-15 DOI: 10.1080/09286586.2024.2378757
Mufida Muhammad, Johnny Vang, Dmitry Tumin

Background: In the US, routine vision care and medical services are often covered by separate insurance plans. Unmet needs for vision care are more common among adults with gaps in medical coverage, but it is unclear how gaps in medical coverage correlate with lack of vision benefits among currently insured adults. We hypothesized that gaps in medical coverage in the past 12 months would be associated with lack of coverage for vision care among US adults currently covered by commercial medical insurance.

Methods: We included adults age 18-65 with private insurance who participated in the 2019-2022 National Health Interview Survey. The primary outcome was any coverage for vision care services, and the secondary outcome was a source of vision coverage (primary health insurance policy as compared to single-service plans only).

Results: Based on a sample of 50,000 participants, we estimated 4% of commercially insured adults recently experienced coverage gaps, and 75% had coverage for vision care services. On multivariable analysis, commercially insured adults with recent gaps in medical coverage were more likely to lack coverage for vision care at the time of the survey, compared to adults with continuous medical coverage (odds ratio [OR], 0.77; 95% CI: 0.68, 0.86). However, medical coverage gaps were not associated with source of vision care coverage.

Conclusions: Gaps in medical insurance coverage were associated with lower likelihood of vision care coverage compared to continuous medical coverage. Protecting continuity of health insurance may support access to vision benefits and reduce gaps in routine vision care.

背景:在美国,常规视力保健和医疗服务通常由不同的保险计划承保。在医疗保险存在缺口的成年人中,视力保健需求未得到满足的情况更为普遍,但目前还不清楚医疗保险缺口与当前投保成年人缺乏视力福利之间的关联。我们假设,过去 12 个月的医疗保险缺口与目前有商业医疗保险的美国成年人缺乏视力保健福利有关:我们纳入了参加 2019-2022 年全国健康访谈调查的 18-65 岁有私人保险的成年人。主要结果是视力保健服务的任何承保范围,次要结果是视力保险的来源(主要医疗保险政策与仅单一服务计划相比):结果:根据 50,000 名参与者的样本,我们估计有 4% 的商业保险成年人最近出现了保险缺口,75% 的人拥有视力保健服务保险。通过多变量分析发现,与拥有连续医疗保险的成年人相比,最近有医疗保险缺口的商业保险成年人在接受调查时更有可能没有视力保健服务(几率比 [OR],0.77;95% CI:0.68,0.86)。然而,医疗保险缺口与视力保健保险来源无关:结论:与连续的医疗保险相比,医疗保险缺口与视力保健投保可能性较低有关。保护医疗保险的连续性可以帮助人们获得视力福利,减少常规视力保健的缺口。
{"title":"Association of Gaps in Medical Insurance Coverage with Vision Care Benefits Among US Adults.","authors":"Mufida Muhammad, Johnny Vang, Dmitry Tumin","doi":"10.1080/09286586.2024.2378757","DOIUrl":"https://doi.org/10.1080/09286586.2024.2378757","url":null,"abstract":"<p><strong>Background: </strong>In the US, routine vision care and medical services are often covered by separate insurance plans. Unmet needs for vision care are more common among adults with gaps in medical coverage, but it is unclear how gaps in medical coverage correlate with lack of vision benefits among currently insured adults. We hypothesized that gaps in medical coverage in the past 12 months would be associated with lack of coverage for vision care among US adults currently covered by commercial medical insurance.</p><p><strong>Methods: </strong>We included adults age 18-65 with private insurance who participated in the 2019-2022 National Health Interview Survey. The primary outcome was any coverage for vision care services, and the secondary outcome was a source of vision coverage (primary health insurance policy as compared to single-service plans only).</p><p><strong>Results: </strong>Based on a sample of 50,000 participants, we estimated 4% of commercially insured adults recently experienced coverage gaps, and 75% had coverage for vision care services. On multivariable analysis, commercially insured adults with recent gaps in medical coverage were more likely to lack coverage for vision care at the time of the survey, compared to adults with continuous medical coverage (odds ratio [OR], 0.77; 95% CI: 0.68, 0.86). However, medical coverage gaps were not associated with source of vision care coverage.</p><p><strong>Conclusions: </strong>Gaps in medical insurance coverage were associated with lower likelihood of vision care coverage compared to continuous medical coverage. Protecting continuity of health insurance may support access to vision benefits and reduce gaps in routine vision care.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-7"},"PeriodicalIF":1.7,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness of Addressing Retinopathy of Prematurity in Rwanda. 卢旺达早产儿视网膜病变治疗的成本效益。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-15 DOI: 10.1080/09286586.2024.2372803
Connor J Alder, Francis Mutangana, Victoria Phillips, Edmund R Becker, Neil S Fleming, Sherwin J Isenberg, Scott R Lambert, Tahvi D Frank

Purpose: With the expansion of neonatal care in sub-Saharan Africa (SSA), an increasing number of premature babies are at risk to develop retinopathy of prematurity (ROP). Previous studies have quantified the cost-effectiveness of addressing ROP in middle-income countries, but few have focused on SSA. This study estimates the cost of a national program for ROP screening and anti-VEGF injection treatment in Rwanda compared to the status quo.

Methods: Medical cost data were collected from King Faisal Hospital in Rwanda (July 2022). Societal burden of vision loss included lost productivity and quality-adjusted life years (QALYs). Published data on epidemiology and natural history of ROP were used to estimate burden and sequelae of ROP in Rwanda. Cost of a national program for screening and treating a one-year birth cohort was compared to the status quo using a decision analysis model.

Results: Cost of ROP screening and treatment was $738 per infant. The estimated equipment cost necessary for the startup of a national program was $58,667. We projected that a national program could avert 257 cases of blindness in the cohort and increase QALYs compared to the status quo. Screening and treatment for ROP would save an estimated $270,000 for the birth cohort from reductions in lost productivity.

Conclusion: The cost of screening and anti-VEGF treatment for ROP is substantially less than the indirect cost of vision loss due to ROP. Allocating additional funding towards expansion of ROP screening and treatment is cost-saving from a societal perspective compared to current practice.

目的:随着撒哈拉以南非洲地区(SSA)新生儿护理范围的扩大,越来越多的早产儿面临罹患早产儿视网膜病变(ROP)的风险。以往的研究对中等收入国家应对早产儿视网膜病变的成本效益进行了量化,但很少有研究关注撒哈拉以南非洲地区。本研究估算了卢旺达全国性早产儿视网膜病变筛查和抗血管内皮生长因子注射治疗项目的成本与现状的比较:医疗成本数据来自卢旺达费萨尔国王医院(2022 年 7 月)。视力丧失造成的社会负担包括生产力损失和质量调整生命年(QALYs)。已发表的关于早产儿视网膜病变流行病学和自然病史的数据用于估算卢旺达早产儿视网膜病变的负担和后遗症。利用决策分析模型对筛查和治疗一岁出生队列的全国性计划的成本与现状进行了比较:结果:每个婴儿的视网膜病变筛查和治疗成本为 738 美元。启动一项全国性计划所需的设备成本估计为 58,667 美元。我们预测,与现状相比,全国性项目可避免 257 例失明,并增加 QALY。筛查和治疗早产儿视网膜病变可减少生产力损失,估计可为出生队列节省 27 万美元:结论:筛查和抗血管内皮生长因子治疗早产儿视网膜病变的成本大大低于早产儿视网膜病变导致视力丧失的间接成本。与目前的做法相比,从社会角度来看,为扩大早产儿视网膜病变筛查和治疗的范围而划拨额外资金可节约成本。
{"title":"Cost-Effectiveness of Addressing Retinopathy of Prematurity in Rwanda.","authors":"Connor J Alder, Francis Mutangana, Victoria Phillips, Edmund R Becker, Neil S Fleming, Sherwin J Isenberg, Scott R Lambert, Tahvi D Frank","doi":"10.1080/09286586.2024.2372803","DOIUrl":"10.1080/09286586.2024.2372803","url":null,"abstract":"<p><strong>Purpose: </strong>With the expansion of neonatal care in sub-Saharan Africa (SSA), an increasing number of premature babies are at risk to develop retinopathy of prematurity (ROP). Previous studies have quantified the cost-effectiveness of addressing ROP in middle-income countries, but few have focused on SSA. This study estimates the cost of a national program for ROP screening and anti-VEGF injection treatment in Rwanda compared to the status quo.</p><p><strong>Methods: </strong>Medical cost data were collected from King Faisal Hospital in Rwanda (July 2022). Societal burden of vision loss included lost productivity and quality-adjusted life years (QALYs). Published data on epidemiology and natural history of ROP were used to estimate burden and sequelae of ROP in Rwanda. Cost of a national program for screening and treating a one-year birth cohort was compared to the status quo using a decision analysis model.</p><p><strong>Results: </strong>Cost of ROP screening and treatment was $738 per infant. The estimated equipment cost necessary for the startup of a national program was $58,667. We projected that a national program could avert 257 cases of blindness in the cohort and increase QALYs compared to the status quo. Screening and treatment for ROP would save an estimated $270,000 for the birth cohort from reductions in lost productivity.</p><p><strong>Conclusion: </strong>The cost of screening and anti-VEGF treatment for ROP is substantially less than the indirect cost of vision loss due to ROP. Allocating additional funding towards expansion of ROP screening and treatment is cost-saving from a societal perspective compared to current practice.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-9"},"PeriodicalIF":1.7,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Status, Hotspots, and Prospects of Artificial Intelligence in Ophthalmology: A Bibliometric Analysis (2003-2023). 人工智能在眼科领域的应用现状、热点和前景:文献计量分析(2003-2023 年)》。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-15 DOI: 10.1080/09286586.2024.2373956
Jie Deng, YuHui Qin

Purpose: Artificial intelligence (AI) has gained significant attention in ophthalmology. This paper reviews, classifies, and summarizes the research literature in this field and aims to provide readers with a detailed understanding of the current status and future directions, laying a solid foundation for further research and decision-making.

Methods: Literature was retrieved from the Web of Science database. Bibliometric analysis was performed using VOSviewer, CiteSpace, and the R package Bibliometrix.

Results: The study included 3,377 publications from 4,035 institutions in 98 countries. China and the United States had the most publications. Sun Yat-sen University is a leading institution. Translational Vision Science & Technology"published the most articles, while "Ophthalmology" had the most co-citations. Among 13,145 researchers, Ting DSW had the most publications and citations. Keywords included "Deep learning," "Diabetic retinopathy," "Machine learning," and others.

Conclusion: The study highlights the promising prospects of AI in ophthalmology. Automated eye disease screening, particularly its core technology of retinal image segmentation and recognition, has become a research hotspot. AI is also expanding to complex areas like surgical assistance, predictive models. Multimodal AI, Generative Adversarial Networks, and ChatGPT have driven further technological innovation. However, implementing AI in ophthalmology also faces many challenges, including technical, regulatory, and ethical issues, and others. As these challenges are overcome, we anticipate more innovative applications, paving the way for more effective and safer eye disease treatments.

目的:人工智能(AI)在眼科领域受到了广泛关注。本文对该领域的研究文献进行了回顾、分类和总结,旨在让读者详细了解该领域的现状和未来发展方向,为进一步的研究和决策奠定坚实的基础:方法:从 Web of Science 数据库中检索文献。方法:从 Web Science 数据库中检索文献,使用 VOSviewer、CiteSpace 和 R 软件包 Bibliometrix 进行文献计量分析:研究包括来自 98 个国家 4035 个机构的 3,377 篇出版物。中国和美国的出版物最多。中山大学在这方面处于领先地位。Translational Vision Science & Technology "发表的文章最多,而 "Ophthalmology "被联合引用的次数最多。在 13145 名研究人员中,丁大伟发表的论文和被引用的次数最多。关键词包括 "深度学习"、"糖尿病视网膜病变"、"机器学习 "等:这项研究凸显了人工智能在眼科领域的广阔前景。自动眼病筛查,尤其是其核心技术--视网膜图像分割和识别,已成为研究热点。人工智能还在向手术辅助、预测模型等复杂领域扩展。多模态人工智能、生成式对抗网络和 ChatGPT 推动了进一步的技术创新。然而,在眼科领域实施人工智能还面临着许多挑战,包括技术、监管和伦理问题等。随着这些挑战的克服,我们预计会有更多的创新应用,为更有效、更安全的眼科疾病治疗铺平道路。
{"title":"Current Status, Hotspots, and Prospects of Artificial Intelligence in Ophthalmology: A Bibliometric Analysis (2003-2023).","authors":"Jie Deng, YuHui Qin","doi":"10.1080/09286586.2024.2373956","DOIUrl":"https://doi.org/10.1080/09286586.2024.2373956","url":null,"abstract":"<p><strong>Purpose: </strong>Artificial intelligence (AI) has gained significant attention in ophthalmology. This paper reviews, classifies, and summarizes the research literature in this field and aims to provide readers with a detailed understanding of the current status and future directions, laying a solid foundation for further research and decision-making.</p><p><strong>Methods: </strong>Literature was retrieved from the Web of Science database. Bibliometric analysis was performed using VOSviewer, CiteSpace, and the R package Bibliometrix.</p><p><strong>Results: </strong>The study included 3,377 publications from 4,035 institutions in 98 countries. China and the United States had the most publications. Sun Yat-sen University is a leading institution. Translational Vision Science & Technology\"published the most articles, while \"Ophthalmology\" had the most co-citations. Among 13,145 researchers, Ting DSW had the most publications and citations. Keywords included \"Deep learning,\" \"Diabetic retinopathy,\" \"Machine learning,\" and others.</p><p><strong>Conclusion: </strong>The study highlights the promising prospects of AI in ophthalmology. Automated eye disease screening, particularly its core technology of retinal image segmentation and recognition, has become a research hotspot. AI is also expanding to complex areas like surgical assistance, predictive models. Multimodal AI, Generative Adversarial Networks, and ChatGPT have driven further technological innovation. However, implementing AI in ophthalmology also faces many challenges, including technical, regulatory, and ethical issues, and others. As these challenges are overcome, we anticipate more innovative applications, paving the way for more effective and safer eye disease treatments.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-14"},"PeriodicalIF":1.7,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thirty-Year Trends in the Prevalence and Severity of Diabetic Retinopathy at the First Visit in Patients with Untreated Type 2 Diabetes Mellitus. 未经治疗的 2 型糖尿病患者首次就诊时糖尿病视网膜病变患病率和严重程度的三十年趋势。
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-08 DOI: 10.1080/09286586.2024.2383285
Tetsuya Kubota, Kikue Todoroki-Mori, Masahiko Iwamoto, Toshiko Kobori, Takako Kikuchi, Tazu Tahara, Yukiko Onishi, Michihiro Araki, Masato Kasuga, Yoko Yoshida

Purpose: Although the rate of diabetic retinopathy (DR)-related blindness has decreased in developed countries in recent years, the reasons for this decrease have remained unclear. The prevalence/severity trends of DR at the first visit in patients with untreated type 2 diabetes mellitus (T2DM) patients seen between the1986s and 2018s were assessed.

Methods: A total of 1979 Japanese T2DM patients diagnosed between 1986 and 2018 were divided into four groups by the decade of their first visit: the 1986 years (1986-1987), the 1996 years (1996-1997), the 2006 years (2006-2008), the 2016 years (2016-2018). The DR prevalence/severity trends were assessed.

Results: A significant decrease in the rate of prevalence of DR from the 1986s to 2016s was observed among previously untreated T2DM patients visiting our hospital for the first time (1986s: 25.5%; 1996s: 26.2%; 2006s: 22.2%; and 2016s: 15.6%). The prevalence was significantly higher in females (30.2%) than in males (21.3%). Although the severity trend of DR did not differ significantly among the four measurement years, the rate of simple DR was the highest in the 2016s.

Conclusion: We found, for the first time, a significant decrease in the rate of prevalence of DR from the 1986s to 2016s in patients with untreated T2DM visiting our hospital for the first time. A decrease in the rate of DR prevalence could explain, at least in part, the observed reduction in the rate of blindness in patients with T2DM.

目的:虽然近年来发达国家与糖尿病视网膜病变(DR)相关的失明率有所下降,但下降的原因仍不清楚。研究评估了1986-2018年间未接受治疗的2型糖尿病(T2DM)患者首次就诊时DR的患病率/严重程度趋势:将1986年至2018年间确诊的1979名日本T2DM患者按初诊年代分为四组:1986年(1986-1987年)、1996年(1996-1997年)、2006年(2006-2008年)、2016年(2016-2018年)。对 DR 发病率/严重程度趋势进行了评估:从 1986 年代到 2016 年代,首次到本医院就诊的既往未经治疗的 T2DM 患者的 DR 患病率明显下降(1986 年代:25.5%;1996 年代:26.2%;2006 年代:22.2%;2016 年代:15.6%)。女性发病率(30.2%)明显高于男性(21.3%)。虽然 DR 的严重程度趋势在四个测量年份之间没有显著差异,但 2016 年代的单纯 DR 患病率最高:我们首次发现,从 1986 年代到 2016 年代,首次到我院就诊的未经治疗的 T2DM 患者的 DR 患病率显著下降。DR 患病率的下降至少可以部分解释所观察到的 T2DM 患者失明率的下降。
{"title":"Thirty-Year Trends in the Prevalence and Severity of Diabetic Retinopathy at the First Visit in Patients with Untreated Type 2 Diabetes Mellitus.","authors":"Tetsuya Kubota, Kikue Todoroki-Mori, Masahiko Iwamoto, Toshiko Kobori, Takako Kikuchi, Tazu Tahara, Yukiko Onishi, Michihiro Araki, Masato Kasuga, Yoko Yoshida","doi":"10.1080/09286586.2024.2383285","DOIUrl":"https://doi.org/10.1080/09286586.2024.2383285","url":null,"abstract":"<p><strong>Purpose: </strong>Although the rate of diabetic retinopathy (DR)-related blindness has decreased in developed countries in recent years, the reasons for this decrease have remained unclear. The prevalence/severity trends of DR at the first visit in patients with untreated type 2 diabetes mellitus (T2DM) patients seen between the1986s and 2018s were assessed.</p><p><strong>Methods: </strong>A total of 1979 Japanese T2DM patients diagnosed between 1986 and 2018 were divided into four groups by the decade of their first visit: the 1986 years (1986-1987), the 1996 years (1996-1997), the 2006 years (2006-2008), the 2016 years (2016-2018). The DR prevalence/severity trends were assessed.</p><p><strong>Results: </strong>A significant decrease in the rate of prevalence of DR from the 1986s to 2016s was observed among previously untreated T2DM patients visiting our hospital for the first time (1986s: 25.5%; 1996s: 26.2%; 2006s: 22.2%; and 2016s: 15.6%). The prevalence was significantly higher in females (30.2%) than in males (21.3%). Although the severity trend of DR did not differ significantly among the four measurement years, the rate of simple DR was the highest in the 2016s.</p><p><strong>Conclusion: </strong>We found, for the first time, a significant decrease in the rate of prevalence of DR from the 1986s to 2016s in patients with untreated T2DM visiting our hospital for the first time. A decrease in the rate of DR prevalence could explain, at least in part, the observed reduction in the rate of blindness in patients with T2DM.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-8"},"PeriodicalIF":1.7,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Intraoperative Cataract Surgical Complications and Mortality. 白内障手术术中并发症与死亡率之间的关系
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-08 DOI: 10.1080/09286586.2024.2382155
Sophia Sidhu, Nathan C Grove, Jennifer L Patnaik, Anne M Lynch, Karen L Christopher

Purpose: To evaluate the association between intraoperative complications of cataract surgery and postoperative mortality.

Methods: A retrospective review of patients who underwent cataract surgery at our institution from 2014 to 2020 was conducted. Intraoperative complications included choroidal hemorrhage, posterior capsule rupture, vitreous loss, retained lens, and/or severe zonular dialysis in either eye. All-cause mortality statistics were obtained through a collaborative agreement with the Colorado Department of Public Health and Environment. Hazard ratios (HRs) from Cox proportional hazard models were used to estimate survival following cataract surgery.

Results: Among 8,054 patients, the mean follow-up time was 4.4 (SD = 2.3) years and the mortality rate was 15% (n = 1,175). The overall complication rate was 2.2% (n = 181), and the rate of retained lens was 0.7% (n = 58). In univariate analysis, retained lens (HR: 1.86, 95% CI: 1.08-3.21, p = 0.026), severe zonular dialysis (HR: 2.00, 95% CI: 1.29-3.12, p = 0.002), and any intraoperative complication (HR: 1.51, 95% CI: 1.09-2.11, p = 0.015) were associated with higher hazard of mortality. When adjusted for demographic factors, comorbid medical conditions, and pre-operative visual acuity, intraoperative complications were not associated with mortality.

Conclusion: Intraoperative cataract surgery complications were associated with mortality in univariate analysis. However, this association was not significant in the multivariable analysis as it is confounded by other factors such as pre-operative visual acuity.

目的:评估白内障手术术中并发症与术后死亡率之间的关系:对 2014 年至 2020 年期间在我院接受白内障手术的患者进行回顾性分析。术中并发症包括脉络膜出血、后囊破裂、玻璃体脱落、晶状体滞留和/或两眼严重虹膜透析。全因死亡率统计数据是通过与科罗拉多州公共卫生与环境部的合作协议获得的。利用考克斯比例危险模型得出的危险比(HRs)来估计白内障手术后的存活率:在 8054 名患者中,平均随访时间为 4.4 年(SD = 2.3),死亡率为 15%(n = 1175)。总体并发症发生率为 2.2%(n = 181),晶状体滞留率为 0.7%(n = 58)。在单变量分析中,滞留晶状体(HR:1.86,95% CI:1.08-3.21,p = 0.026)、重度带状透析(HR:2.00,95% CI:1.29-3.12,p = 0.002)和任何术中并发症(HR:1.51,95% CI:1.09-2.11,p = 0.015)与较高的死亡率相关。在对人口统计学因素、合并症和术前视力进行调整后,术中并发症与死亡率无关:结论:在单变量分析中,术中白内障手术并发症与死亡率有关。结论:在单变量分析中,术中白内障手术并发症与死亡率有关,但由于受到术前视力等其他因素的影响,这种关联在多变量分析中并不显著。
{"title":"Association Between Intraoperative Cataract Surgical Complications and Mortality.","authors":"Sophia Sidhu, Nathan C Grove, Jennifer L Patnaik, Anne M Lynch, Karen L Christopher","doi":"10.1080/09286586.2024.2382155","DOIUrl":"https://doi.org/10.1080/09286586.2024.2382155","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the association between intraoperative complications of cataract surgery and postoperative mortality.</p><p><strong>Methods: </strong>A retrospective review of patients who underwent cataract surgery at our institution from 2014 to 2020 was conducted. Intraoperative complications included choroidal hemorrhage, posterior capsule rupture, vitreous loss, retained lens, and/or severe zonular dialysis in either eye. All-cause mortality statistics were obtained through a collaborative agreement with the Colorado Department of Public Health and Environment. Hazard ratios (HRs) from Cox proportional hazard models were used to estimate survival following cataract surgery.</p><p><strong>Results: </strong>Among 8,054 patients, the mean follow-up time was 4.4 (SD = 2.3) years and the mortality rate was 15% (<i>n</i> = 1,175). The overall complication rate was 2.2% (<i>n</i> = 181), and the rate of retained lens was 0.7% (<i>n</i> = 58). In univariate analysis, retained lens (HR: 1.86, 95% CI: 1.08-3.21, <i>p</i> = 0.026), severe zonular dialysis (HR: 2.00, 95% CI: 1.29-3.12, <i>p</i> = 0.002), and any intraoperative complication (HR: 1.51, 95% CI: 1.09-2.11, <i>p</i> = 0.015) were associated with higher hazard of mortality. When adjusted for demographic factors, comorbid medical conditions, and pre-operative visual acuity, intraoperative complications were not associated with mortality.</p><p><strong>Conclusion: </strong>Intraoperative cataract surgery complications were associated with mortality in univariate analysis. However, this association was not significant in the multivariable analysis as it is confounded by other factors such as pre-operative visual acuity.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-7"},"PeriodicalIF":1.7,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Multimorbidity and Presence of Diagnosed Vision Problems Among the Middle-Aged and Older Population in India. 印度中老年人群的多病症与确诊视力问题之间的关系
IF 1.7 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-08-08 DOI: 10.1080/09286586.2024.2384061
Trupti Meher, T Muhammad, Waquar Ahmed

Purpose: The aim of the study was to estimate the prevalence of diagnosed vision problems and to examine the association of single and multiple chronic conditions with vision problems among middle-aged and older adults in India.

Methods: The study utilized data from the Longitudinal Ageing Study in India (LASI) Wave 1, (2017-18). Descriptive statistics along with bivariate and multivariable analyses were conducted to achieve the study objectives.

Results: The prevalence of diagnosed vision problems in the sampled population was 48.2%. The older adults (60+ years) (55.3%) had shown a greater prevalence of vision problems than the middle-aged individuals (41%). Among chronic conditions, hypertension, diabetes, chronic lung diseases, chronic heart diseases, bone related diseases, psychiatric disorders, and high cholesterol were significantly associated with vision problems in the case of both middle-aged and older adults. Furthermore, odds of experiencing vision problems according to the presence of multimorbidity were higher in the middle-aged population [adjusted odds ratio (AOR) = 1.986; confidence interval (CI):1.855-2.126] than in the older population [AOR = 1.746; CI:1.644-1.854].

Conclusions: Middle-aged and older adults with chronic illnesses and multimorbidity were at greater risk of vision problems. Due to the high prevalence of vision problem, interventions aimed at prevention or early detection are warranted.

目的:本研究旨在估算印度中老年人中已确诊视力问题的患病率,并研究单一和多种慢性疾病与视力问题之间的关联:研究利用了印度老龄化纵向研究(LASI)第 1 波(2017-18 年)的数据。为实现研究目标,研究人员进行了描述性统计以及双变量和多变量分析:抽样人群中确诊视力问题的发生率为 48.2%。老年人(60 岁以上)(55.3%)的视力问题发生率高于中年人(41%)。在慢性疾病中,高血压、糖尿病、慢性肺病、慢性心脏病、骨骼相关疾病、精神疾病和高胆固醇与中老年人的视力问题有显著相关性。此外,中年人群出现视力问题的几率(调整后几率比(AOR)=1.986;置信区间(CI):1.855-2.126)高于老年人群(AOR=1.746;CI:1.644-1.854):结论:患有慢性病和多病的中老年人出现视力问题的风险更大。结论:患有慢性疾病和多病的中老年人出现视力问题的风险更大。由于视力问题的发病率很高,因此有必要采取干预措施来预防或早期发现视力问题。
{"title":"Association Between Multimorbidity and Presence of Diagnosed Vision Problems Among the Middle-Aged and Older Population in India.","authors":"Trupti Meher, T Muhammad, Waquar Ahmed","doi":"10.1080/09286586.2024.2384061","DOIUrl":"https://doi.org/10.1080/09286586.2024.2384061","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of the study was to estimate the prevalence of diagnosed vision problems and to examine the association of single and multiple chronic conditions with vision problems among middle-aged and older adults in India.</p><p><strong>Methods: </strong>The study utilized data from the Longitudinal Ageing Study in India (LASI) Wave 1, (2017-18). Descriptive statistics along with bivariate and multivariable analyses were conducted to achieve the study objectives.</p><p><strong>Results: </strong>The prevalence of diagnosed vision problems in the sampled population was 48.2%. The older adults (60+ years) (55.3%) had shown a greater prevalence of vision problems than the middle-aged individuals (41%). Among chronic conditions, hypertension, diabetes, chronic lung diseases, chronic heart diseases, bone related diseases, psychiatric disorders, and high cholesterol were significantly associated with vision problems in the case of both middle-aged and older adults. Furthermore, odds of experiencing vision problems according to the presence of multimorbidity were higher in the middle-aged population [adjusted odds ratio (AOR) = 1.986; confidence interval (CI):1.855-2.126] than in the older population [AOR = 1.746; CI:1.644-1.854].</p><p><strong>Conclusions: </strong>Middle-aged and older adults with chronic illnesses and multimorbidity were at greater risk of vision problems. Due to the high prevalence of vision problem, interventions aimed at prevention or early detection are warranted.</p>","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-9"},"PeriodicalIF":1.7,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ophthalmic epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1